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Nitric oxide production in renal cells by immune complexes: Nitric oxide (NO) is an important effector molecule
Role of kinases and nuclear factor-B. both in physiological conditions and in disease states char-
Background. Interaction of deposited immune complexes acterized by inflammation. NO radicals are synthesized(IC) with Fc receptors (FcR) on tissue cells elicits the release
from l-arginine by NO synthase, from which three iso-of inflammatory mediators leading to tissue damage. Nitric ox-
ide (NO) radicals generated by inducible NO synthase (iNOS) forms can be distinguished: neuronal (nNOS), endothe-
are important mediators in inflammatory processes. To analyze lial (eNOS), and inducible (iNOS) nitric oxide synthase
the role of NO in IC-mediated glomerular inflammation, we [1]. In the kidney, a constitutive NO release within thestudied the in vitro and in vivo expression of iNOS in renal
glomerular vasculature may be protective by decreasingcells [resident mesangial cells (MC), and infiltrating monocytes]
induced by IC, and the possible intermediate steps between glomerular capillary pressure and autoregulating renal
FcR occupancy and iNOS induction. blood flow [2]. However, in pathological conditions, local
Methods. MC and monocytes were stimulated with IgG- and generation of high output induced by various stimuliIgA-containing IC, and NO production (nitrite accumulation),
through the expression of iNOS may result in damagingiNOS transcription (luciferase assay) and their expression was
effects. NO generated by activated cells may amplify themeasured by RT-PCR and Western blot. The involvement
of FcR, transcription factor nuclear factor-B (NF-B), and injury through the production of peroxynitrite and reac-
protein kinases was assessed by using Fc fragments and specific tive oxygen species [3]. In vitro, iNOS expression can
inhibitors. Immune glomerulonephritis was induced in rats,
be induced in leukocytes and renal cells after exposureand iNOS expression and NF-B activation were analyzed.
to cytokines and endotoxin [4–7]. In human and experi-Results. In MC and monocytes, IC enhanced iNOS transcrip-
tion/expression and NO generation, which were attenuated by mental nephritis, the glomerular induction of iNOS me-
specific inhibitors of NF-B. In addition, mitogen-activated diates renal injury [3, 8–10], suggesting that inhibition
protein kinase (MAPK) inhibitors decreased NO production,
of high output NO release by blocking iNOS expressionbut did not interfere with NF-B activity, suggesting that both
or activity may be a useful strategy for treatment ofpathways may converge downstream in the induction of iNOS.
In experimental immune glomerulonephritis, increased iNOS inflammatory disorders. However, conflicting results ex-
expression correlated with proteinuria levels, and appeared ist between the published studies of pharmacologic NO
colocalized with NF-B in glomerular and infiltrating cells.
regulation by unselective or iNOS-specific inhibitors andTreatment of animals and cells with Fc fragments prevented
the experimental glomerulonephritis in iNOS deficientiNOS induction and NF-B activation by IC.
Conclusions. These results indicate that IC, through activa- mice [3, 11–14].
tion of FcR, induce iNOS expression in renal resident and Inducible NOS gene expression is strictly controlled,
recruited cells by mechanisms involving MAPK and NF-B,
mostly at the transcriptional level. The promoter regionand support the idea of the important role of local NO genera-
of iNOS gene has been cloned and sequenced in differenttion in IC-mediated glomerular injury.
species [4, 15], and contains at least one nuclear factor-B
(NF-B) consensus site that has been shown to be impor-
tant for iNOS transcription in macrophages and mesan-
gial cells (MC) [7, 16]. NF-B is a ubiquitous and rapidKey words: immune complexes, Fc receptors, nitric oxide, glomerulo-
nephritis, NF-B, tissue injury, inflammation. transcription factor in several cells in response to cyto-
kines and other stimuli, and exerts its effect by regulating
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logically mediated diseases such as glomerulonephritis, binant human interferon- (rhIFN), and recombinant
human interleukin-1 (rhIL-1). The specific antibodiesallograft rejection, and rheumatoid arthritis [17, 21].
Deposition/formation of immune complexes (IC) in (Abs) used were: rabbit anti-rat iNOS, goat anti-human
iNOS, and rabbit anti-p50 (Chemicon International, Te-the glomeruli is the pathogenic factor that triggers the
inflammatory cascade leading to tissue damage [22]. In mecula, CA, USA); goat anti-IB, goat anti-p65, rabbit
anti-p38, mouse anti-p-p38, goat anti-ERK1/2, and mouseaddition to their capacity to activate the complement
system, IC interact with Fc receptors (FcR) of resident anti-p-extracellular-signal-related kinase (ERK) (sc-371,
sc-109, sc-535, sc-7973, sc154, and sc-7383; Santa Cruzand infiltrating cells and trigger several signaling path-
ways, thus resulting in the secretion of a wide array Biotechnology, Santa Cruz, CA, USA).
of chemical mediators [23]. In cultured MC, IgG- and
Cell cultureIgA-containing IC elicit synthesis of proinflammatory
and profibrogenic cytokines through a mechanism de- Mesangial cells (MC) were obtained from human and
rat kidneys as described [31] and cultured in RPMI 1640pending on the Fc region of the Ig [24–28]. These data
are of particular importance because the MC, the major medium with 25 mmol/L HEPES, pH 7.4, supplemented
with 10% fetal calf serum (FCS), 100 U/mL penicillin,determinant in the regulation of glomerular filtration
rate [29], is known to play a key role during immune 100 g/mL streptomycin, and 2 mmol/L glutamine (Life
Technologies, Paisley, Scotland, UK). MC were charac-glomerulonephritis, with an active participation in prolif-
eration, synthesis of mediators and matrix deposition terized by phase contrast microscopy, positive staining
for desmin and vimentin and negative staining for factor[30]. In our current study, we have focused on a highly
versatile member of this orchestra of inflammatory medi- VIII and cytokeratin. The human monocytic cell line
THP-1 (American Type Culture Collection, Rockville,ators, NO, because its excessive formation may alter the
glomerular filtration, but also may cause tissue injury MD, USA) was cultured in RPMI with 10% FCS. Cells
were made quiescent by 24 hours of incubation in theand thus contribute to the pathogenesis of IC-mediated
glomerulonephritis. We examined the in vitro and in medium containing 0.5% FCS. In some cases, cells were
preincubated for 90 minutes with inhibitors or Ig frag-vivo expression of iNOS in renal cells (resident MC and
infiltrating monocytes) after stimulation with IC. Be- ments, washed and then stimulated with IC.
cause the signaling pathway utilized by IC in iNOS induc-
Experimental model of immune nephritistion is not well elucidated, we also studied the possible
intermediate steps between FcR occupancy and iNOS Female Wistar rats (200 g) were immunized with oval-
bumin according to a previously described protocol [33].expression in MC and monocytes.
The study groups included healthy control rats (N  8)
and those with spontaneous development of nephritis
METHODS
(N  12). Rats were maintained in metabolic cages and
Reagents and chemicals 24 hour proteinuria was measured by the sulfosalicylic
method. Two phases were considered in the group ofMonomeric human IgG and IgA were purified from
patient serum by affinity and gel filtration chromatogra- nephritic rats: mild nephritis (proteinuria 100 mg/24 h,
N  5) and severe nephritis (proteinuria 100 mg/24 h,phy as described [26], and were heat aggregated at 63	C
for 30 and 150 minutes, respectively. After removing in- N  7). Administration of IgG Fc fragments (5 mg/kg/
day, IP) [31] was performed in animals with ongoingsoluble aggregates and monomeric immunoglobulins (Igs),
soluble aggregates were used for cell stimulation because nephritis (proteinuria 20 to 50 mg/24 h) and continued
during one (N  4) and two (N  4) weeks. Controlthey present physicochemical properties similar to IC.
IgG Fc fragments were obtained by digestion with acti- animals receiving Fc fragments for two weeks (N  4)
were studied also. In each group, the rats were sacrificedvated papain (Sigma Chemicals, St. Louis, MO, USA).
IgA fragments were obtained by digestion with pepsin and the kidneys were removed. The renal cortex was
snap frozen in liquid nitrogen or immersed in 10% neu-[F(ab
)2] or with protease from Haemophilus Influenzae
(Fc and Fab) [31, 32]. The presence of endotoxin in all tral buffered formalin and embedded in paraffin.
preparations was excluded with the Limulus amebocyte
Determination of nitritesassay (Ingelheim Diagnostica, Barcelona, Spain). Pyrrol-
idine dithiocarbamate (PDTC), parthenolide, lipopolysac- Nitric oxide released from cells was determined by
the accumulation of nitrites and measured by fluorescentcharide (LPS), N-nitro-l-arginine methyl ester (L-NAME)
and polymyxin B were provided by Sigma. Genistein, reaction of nitrite with 2,3-diaminonaphthalene. On the
day of the experiment, cells were washed and stimulatedMG132, SB203580 and PD98059 were purchased from
Calbiochem (La Jolla, CA, USA). Immunegenex Corpo- in medium RPMI devoid of Phenol Red. Cell cultures (5
105/mL) were filled with 100 L of a solution (1 mmol/Lration (Los Angeles, CA, USA) provided us with recom-
binant human tumor necrosis factor- (rhTNF-), recom- sulfanilic acid and 100 mmol/L HCl). Medium was as-
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pirated, centrifuged and incubated with 1 mmol/L 2,3- 0.5% NP-40, 1 mmol/L egtazic acid (EGTA), 1 mmol/L
ethylenediaminetetraacetic acid (EDTA), 0.2 mmol/Ldiaminonaphthalene. The absorbance at 548 nm was
measured and compared with a standard of NaNO2. The Na3VO4, 100 mmol/L NaF, 0.2 mmol/L phenylmethylsul-
fonyl fluoride (PMSF), and protease inhibitors cocktail.production of NO was expressed as nmol of NO2 per
milligram of protein. Cytosolic proteins (20g) were resolved on 10% or 12.5%
acrylamide gels and transferred to polyvinylidene diflu-
Analysis of mRNA expression oride (PVDF) membranes (Immobilon P; Millipore, Bed-
ford, MA, USA). After blocking with 8% milk, the mem-Total RNA from cells or renal cortex was obtained by
the acid guanidine-thiocyanate-phenol-chloroform method branes were incubated with Abs against human iNOS
(5 g/mL), IB (10 g/mL), p-p38 (0.4 g/mL) andand the iNOS mRNA expression was analyzed by reverse
transcription-polymerase chain reaction (RT-PCR) us- p-ERK (0.4 g/mL), followed by peroxidase-conjugated
secondary Ab and a chemiluminescent detection systeming the following primers. Human iNOS (259bp): sense,
5
-CGGTGCTGTATTTCCTTACGAGGCGAAGA (ECL; Amersham, Buckinghamshire, UK). After prob-
ing phosphorylated proteins, the membranes were strippedAGG-3
; antisense, 5
-GTGCTGCTTGTTAGGAGGT
CAAGTAAAGGGC-3
. Rat iNOS (223 bp): sense, and probed with anti-p38 or anti-ERK1/2 Abs for deter-
mining equal loading of proteins between samples.5
-TGCATGGACCAGTATAAGGCAAAC-3
; anti-
sense, 5
-GTTTCTGGTCGATGTCATGAGCAA-3
.
Kinase assayThe expression of GPDH was used as internal control.
The p38 and ERK proteins were immunoprecipitated
Transient transfection and luciferase assay using specific Abs at 4	C for 16 hours (200 g protein/
1 g Ab). Protein G agarose beads were added for fourThe plasmids containing cDNA for the iNOS promoter
and the luciferase reporter gene (piNOS-Luc) were a hours, and precipitates were washed and diluted in ki-
nase buffer [20 mmol/L Hepes pH 7.6, 20 mmol/L MgCl2,gift from Dr. Santiago Lamas (Centro de Investigaciones
Biolo´gicas, Madrid, Spain). Two different fragments of 20 mmol/L glycerophosphate, 0.2 mmol/L dithiothreitol
(DTT), 10 mmol/L NaF, 0.2 mmol/L Na3VO4]. Kinasethe 5
 regulatory region of iNOS were cloned into a luci-
ferase reporter plasmid (pGL-3) [7]: the 727 bp fragment reactions were performed in the presence of 10 g of
the myelo basic protein (MBP) as a substrate and 1 Ci(0.7 kb-piNOS-Luc) and the 388 bp fragment (0.3 kb-
piNOS-Luc). Growth-arrested cells (1  105) on six-well [-32P]ATP at 30	C for 30 minutes, and then stopped by
additions of 5 Laemmli sample buffer. Samples wereplates were cotransfected with piNOS-Luc and a second
reported vector (pRL-TK vector containing the Renilla resolved on 15% acrylamide gels, and phosphorylation
of substrate was examined by autoradiography. As theluciferase gene; Promega, Madison, WI, USA) at a 10:1
ratio, by using the FuGENE reagent (Roche, Barcelona, control, immunoprecipitates were electrophoresed, trans-
ferred to membranes and probed with anti-p38 or anti-Spain). After 16 hours, cells were stimulated for 24 hours
and luciferase activity in cleared lysate was assayed using ERK Abs.
a luminometer. Firefly luciferase activity was normalized
Immunofluorescence analysisfor total protein content and variations in transfection
efficiency as determined by protein concentration and Mesangial cells were fixed with 3% paraformaldehyde,
and permeabilized with 0.5% Triton X-100. DetectionRenilla luciferase activity measurements, respectively.
of NF-B complex subunits was made by incubation with
Gel shift assay anti-p50 (2 g/mL) and anti-p65 (5 g/mL) Abs, followed
by FITC-labeled anti-IgG. Controls were stained withNuclear proteins (10 g) obtained from cultured cells
[28] were incubated in buffer containing 50 g/mL poly nonimmune serum.
(dI-dC) (Amersham) and 0.035 pmol of [32P]NF-B con-
Immunohistochemistry and Southwestern in situsensus oligonucleotide. The reactions were analyzed on
a 4% nondenaturing polyacrylamide gel and autoradio- Immunohistochemistry for iNOS was analyzed in par-
affin-embedded renal tissues by incubation with 2.5g/mLgraphed. Identification of nuclear proteins bound to the
NF-B oligonucleotide was performed by post-incubat- anti-rat iNOS in PBS containing 4% bovine serum albu-
min (BSA) and 6% goat serum, treatment with peroxi-ing with 1 g of anti-p50 and anti-p65 Abs. Specificity
of the binding reaction was confirmed using a 100-fold dase-conjugated secondary Ab, development with 3,3
-
diaminobenzidine tetrahydrochloride and counterstain-excess of unlabeled probe.
ing with hematoxylin. Negative controls without primary
Western blot analysis Ab were run in parallel. Glomerular lesions were evalu-
ated after hematoxylin and eosin (H&E) and Masson’sAfter stimulation, cells were washed in cold phosphate-
buffered saline (PBS) and lysed in 10 mmol/L Tris-HCl trichrome staining. For histological analysis, approxi-
mately 20 fields from each animal were examined by anpH 7.4 containing 150 mmol/L NaCl, 1% Triton X-100,
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Fig. 1. Production of nitric oxide (NO) by
human mesangial cells (MC) and monocytes
stimulated with immune complexes (IC). Hu-
man MC () and monocytes () were incu-
bated in medium alone or with 200 g/mL
IgA-IC (A) or IgG-IC (B). At the indicated
times the production of NO in the superna-
tants was analyzed by a fluorimetric assay.
Data of nitrite production (nmol/mg protein)
are the means  SD of six experiments per-
formed in triplicate (P  0.001 vs. control
unstimulated cells).
investigator who had no prior knowledge of the experi- 2 and 10  3% inhibition, respectively). Additionally,
endotoxin concentration in the samples was less thanmental design. The glomerular staining was semiquanti-
tatively graded on the following scale: 0, negative, 1, 0.25 U/mL, as determined by Limulus amebocyte assay.
In these experiments the combination of LPS (10weak, 2, moderate, and 3, strong staining.
In situ distribution of activated NF-B was analyzed g/mL) and cytokines (TNF- 100 ng/mL; IFN- 100
U/mL; IL-1 100 U/mL), used as a positive control, in-in paraffin-embedded tissue sections fixed in 0.5% para-
formaldehyde by incubation with 50 pmol of digoxi- duced a high NO production in MC and monocytes
(183  11 and 237  12 nmol/mg protein at 24 h). NOgenin-labeled DNA probe in buffer containing 0.25%
BSA and 1g/mL poly(dI-dC), followed by alkaline phos- formation was abolished upon treatment with 50 mol/L
L-NAME, a competitive NOS inhibitor (MC 89  7%,phatase-conjugated anti-digoxigenin IgG and colorimet-
ric detection [34]. In some cases double immunohisto- monocytes 93  3% inhibition).
chemistry for iNOS was carried out on slides directly
IC induce iNOS expression in MC and monocytesfrom the final wash of the Southwestern histochemistry
protocol (counterstain with hematoxylin was omitted). To assess whether the modulation of NO levels by IC
is associated with changes in the corresponding mRNA
Statistical analysis steady state levels for iNOS, RT-PCR analysis using
specific primers for human iNOS were performed. InData are expressed as mean  SD or representative
result, when indicated. Statistics was performed by using human MC, the time course of iNOS induction was paral-
lel to the NO production, increasing up to seven (IgA-IC)analysis of variance (ANOVA) or Tukey-Kramer tests.
Differences were considered to be significant at P  0.05. and 14 (IgG-IC) hours, and decreasing to near control
levels after 48 hours (Fig. 2A). In monocytes, IgA-IC
dose-dependently induced iNOS mRNA expression (1.9-,
RESULTS
3.2- and 3.8-fold increases with 100, 200 and 300 g/mL
NO generation in human MC and monocytes at 7 h), and the temporal course was very different from
induced by IC that of MC, observing a continuous increase (Fig. 2B).
Similar results were obtained with IgG-IC (not shown).Exposure of human MC and monocytes to IC (200
g/mL) induced a time-response production of NO, mea- Monomeric Igs or F(ab
)2 fragments did not elicit iNOS
expression in both cell types (less than 1.5-fold vs. basal).sured as accumulation of nitrites (a stable oxidative end
product of NO) by fluorimetric assay (Fig. 1). Detectable The iNOS protein induction by IC was analyzed by
Western blot using cytosolic fractions from MC andamounts of nitrite were evident at six hours, with a peak
of production after 24 hours of incubation. Monocytic monocytes. As shown in Figure 2C, IgA-IC drastically
up-regulated the iNOS protein production after 24 hourscells (THP-1 line) produced greater amounts of NO than
MC. The kinetics of IgA-IC (Fig. 1A) and IgG-IC (Fig. of incubation, whereas monomeric IgA had no effect.
The protein detected presented a similar size (130 kD)1B) were very similar, however, IgG-IC was a stronger
stimulus. The response to the same concentration of in both cell types, although it was more abundant in
monocytes. Similar results were observed after incuba-monomeric Igs was undetectable in both cell types (hu-
man MC, IgA 7  3; IgG 9  4; monocytes, IgA 12  tion with IgG monomeric and IC (not shown).
3; IgG 9  1 nmol/mg protein at 24 h).
IC increase the transcriptional activity of theThe possibility of endotoxin contamination in the Ig
iNOS genepreparations was discarded, since preincubation with
polymyxin B (10 g/mL) did not significantly decrease Growth-arrested human MC were transfected with the
plasmids containing the 0.7 kb and 0.3 kb fragments ofmesangial NO generation by IgG-IC and IgA-IC (8 
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Fig. 2. IC stimulate iNOS expression in MC
and monocytes. Growth-arrested human MC
(A) and monocytes (B) were incubated with
200 g/mL of IgA-IC () or IgG-IC () for
different periods of time. Expression of iNOS
was analyzed by RT-PCR (30 amplification
cycles), and the transcripts were analyzed by
electrophoresis and densitometry. Data were
corrected by GAPDH expression, and ex-
pressed as fold increase in relation to control
cells. Mean  SD of 4 to 6 different experi-
ments (*P  0.05 vs. control). (C ) Production
of iNOS protein in MC and monocytes stimu-
lated with monomeric IgA (mon) and IgA-IC
for 24 hours was analyzed by Western blot
with rabbit anti-human iNOS. The combina-
tion of LPS and the cytokines TNF-, IFN-
and IL-1 (LC) was used as a positive con-
trol. One representative of two experiments
is shown.
the 5
 regulatory region of iNOS (0.7 kb and 0.3 kb
piNOS-Luc), and luciferase activity was measured after
24 hours of stimulation with IC. Increasing concentra-
tions of IgA-IC and IgG-IC activated the expression of
the reporter iNOS plasmids, observing a maximal re-
sponse with 300g/mL (Fig. 3). The increase in luciferase
activity was markedly greater when the bigger fragment
of iNOS promoter was used (0.7 kb piNOS-Luc), which
includes NF-B and activator protein-1 (AP-1) sites,
among others. No increase was seen with the empty plas-
mid pGL-3. Treatment with the combination LPS/TNF-/
IFN-/IL-1 for 24 hours was used as the positive control
(8- and 5-fold increases with 0.7 kb and 0.3 kb piNOS-
Luc, respectively; N  3). In monocytes, increased lucif- Fig. 3. Inducible nitric oxide synthase (iNOS) promoter activity in-
duced by IC in human MC. (A) IgA and (B) IgG. Growth-arrestederase activity was observed after incubation with 150
MC were cotransfected with piNOS-Luc (0.7 kb and 0.3 kb fragmentsg/mL of IgA-IC and IgG-IC (5- and 6.5-fold increase
of the 5
 flanking region of the iNOS gene), pGL-3 (empty plasmid),
vs. control cells; N  4, P  0.05), while monomeric Igs and pRL-TK expression vectors. Symbols are: () pGL-3; ( ) 0.3 kb;
( ) 0.7 kb. Cells were stimulated with different doses of IgA-IC orhad no effect (1.2- and 1.4-fold vs. control, N  3).
IgG-IC during 24 hours, and then lysed and assayed for luciferase
activity. The values were normalized to Renilla activity and proteinModulation of IC-induced NO generation by amounts, and are expressed as fold increases, compared with control
inhibitors of kinases and NF-B luciferase activity. Data are the mean  SD of 5 independent experi-
ments each performed in duplicate. (*P  0.01 vs. empty plasmid).The signal transduction pathways involved in the IC-
induced NO generation were analyzed by using inhib-
itors of tyrosine kinases, mitogen-activated protein ki-
nases (MAPK) and NF-B pathway. As indicated in to inhibit the NF-B activation at different levels: oxida-
Figure 4A, NO released by human MC stimulated with tive pathway (PDTC), IB tyrosine phosphorylation
IgA-IC and IgG-IC was significantly decreased in the (parthenolide), and IB degradation (MG132) [35–37].
presence of genistein (tyrosine kinase inhibitor), PD98059 These compounds were unable to block iNOS enzyme
(MEK inhibitor) and SB203580 (p38 MAPK inhibitor). activity (by indirect measurement of NO at 7 h), as no
However, the major inhibition percentages (around 60%) inhibition was observed when the agents were added at
the last hour of incubation with IC (not shown).were observed after treatment with several agents known
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Fig. 4. Mesangial NO production and iNOS expression induced by IC require activation of protein kinases and NF-B. (A) Human MC were
incubated with 150 g/mL of IC alone or after pretreatment with genistein (150 mol/L), PD98059 (50 mol/L), SB203580 (30 mol/L), PDTC
(150 mol/L), MG132 (10 mol/L), or parthenolide (10 mol/L). Symbols are: ( ) IgA-IC; () IgG-IC. The NO production after 24 hours was
analyzed by fluorimetric assay. Data of nitrite production (nmol/mg protein) are mean  SD of 4 experiments performed in triplicate (P  0.05
vs. IC alone). (B) Human MC were preincubated with the indicated inhibitors before stimulation with IgA-IC for 6 hours, and iNOS mRNA
expression was analyzed by RT-PCR. A representative experiment is shown in the upper part of the panel. Densitometry of the iNOS band was
corrected by the GAPDH expression, and data are expressed as fold increases respect to control conditions. Data are means  SD of three
experiments (*P  0.01 vs. IC alone).
The mesangial iNOS mRNA expression induced by activity in IC-stimulated human MC was dramatically
attenuated by parthenolide or MG132 and, to a lesserIC also was significantly reduced when MAPK or NF-B
activity was blocked (Fig. 4B). To extend the above ob- extent, by the p38 inhibitor SB203580 (Fig. 5B). Interest-
ingly, the MEK inhibitor PD98059 was effective in cellsservations to rodent cells, the modulation of rat iNOS
expression was assessed. Rat MC stimulation with IgG-IC transfected with the 0.7 kb plasmid, but not with 0.3 kb
plasmid, which contains NF-B, but not AP-1 sites. This(150 g/mL) for six hours increased the iNOS mRNA
expression (5-fold vs. control cells, N  3), which was suggests that MEK activates iNOS transcription through
the regulation of AP-1.reduced by preincubation with PD98059, parthenolide
and MG132 (52  6, 62  6, and 59  8% inhibition; The pharmacological modulation of NF-B activity in
IC-stimulated cells was assessed by gel shift assay andN  3, P  0.05). Similarly, preincubation of monocytes
with the MEK inhibitor or proteasome inhibitor de- Western blot for IB. Nuclear extracts from IgG-IC and
IgA-IC stimulated cells showed a strong DNA bindingcreased the iNOS expression induced by IgA-IC and
IgG-IC (PD98059 48 9 and 43 5% inhibition; MG132 activity compared with the control, as previously described
[18, 20, 28], and cytosolic proteins revealed a decrease in63  10 and 57  8% inhibition; N  4, P  0.05). Cell
viability assessed by trypan blue exclusion was consis- the intensity of IB band (Fig. 5 C, D). NF-B activity
was attenuated by pretreatment with antioxidants, IBtently greater than 90% under all experimental condi-
tions studied, indicating that these inhibitory effects were phosphorylation inhibitors and proteasome inhibitors
(Table 1), which also prevented IB degradation (Fig.not the result of cytotoxicity.
5C). Interestingly, MAPK inhibitors (SB203580 and
NF-B and MAPK are involved in the transcriptional PD98059) did not significantly affect both IB degra-
induction of iNOS gene by IC dation and NF-B nuclear translocation (Fig. 5 C, D
and Table 1), indicating that NF-B activation of IC-To examine in a more direct manner the upstream
signaling cascades involved in the transcriptional induc- stimulated cells occurs independently of MAPK path-
way. No differences in the subunits of NF-B complextion of iNOS, transfected human MC and monocytes
were pretreated with several inhibitors before IC stimu- were detected in cells treated with the different inhibitors
(PD98059, SB203580, PDTC, parthenolide) comparedlation. In monocytes, inhibition of NF-B or MAPK
pathways partially decreased iNOS transcription induced with non-treated cells after IC stimulation, as assessed
by supershift assay (Fig. 5D and data not shown).by IgG-IC and IgA-IC (Fig. 5A). Similarly, the luciferase
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Fig. 5. NF-B and MAPK pathways independently regulate the IC-induced iNOS transcription. Monocytes transfected with 0.7 kb piNOS-Luc
(A) and human MC transfected with 0.7 kb and 0.3 kb piNOS-Luc (B) were pretreated with different inhibitors of NF-B and MAPK, and then
stimulated for 24 hours with 200 g/mL of IgG-IC (A) and IgA-IC (A, B). Data of luciferase activity are expressed as fold increases vs. control
cells; data are means  SD of 4 experiments in duplicate (*P  0.05 vs. IC alone). Symbols in panel A are: () IgA-IC; ( ) IgG-IC. (C )
Degradation of the inhibitory subunit IB in the cytosol of human MC stimulated with IgA-IC (200 g/mL, 60 min) was prevented when NF-B
inhibitors, but not MAPK inhibitors, were used. Western blots are representative of three experiments. (D) DNA-binding properties of nuclear
proteins from MC activated with IgA-IC were analyzed by gel shift assays using consensus NF-B oligonucleotide and p65 and p50 Abs. Pretreatment
with the MEK inhibitor PD98059 did not modify the intensity of the bands and the composition of activated complexes. Arrows indicate the
position of specific (NF-B) and supershifted (ss) bands. Gel is representative of two experiments.
Further experiments were performed to examine the pattern of ERK phosphorylation was more prolonged,
gradually increasing up to one hour, and remaining sus-effects of IC on the activation of MAPK members ERK
and p38. Since activation of MAPK is dependent on the tained above the basal level after three hours of stimula-
tion (Fig. 6B). A similar pattern of MAPK activationphosphorylation by their respective upstream MAPK
kinases, mesangial lysates were immunoblotted using was observed after IgG-IC incubation (not shown). To
determine whether this augmentation in phosphoryla-phospho-specific Abs to p38 and ERK. As shown in Fig-
ure 6A, phosphorylation of p38 occurred after five min- tion of ERK and p38 was accompanied also by an in-
crease in kinase activity, another portion of the wholeutes of IgA-IC stimulation, peaking at 15 minutes, and
decreased near to control values at three hours. The cell lysate was subjected to in vitro kinase assay with
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Table 1. Inhibition of IC-induced NF-B activity in mainly in the mesangial area, some epithelial and endo-
mesangial cells and monocytes
thelial cells, and in several tubular epithelial cells and
% Inhibition interstitial infiltrating cells (Fig. 7B). A semiquantitative
Mesangial cells Monocytes scoring system was applied for glomerular intensity of
iNOS staining, which correlated with the severity of theInhibitor IgG-IC IgA-IC IgG-IC IgA-IC
disease, as determined by proteinuria levels (Fig. 7C).MG132 10 lmol/L 6410a 5917a ND 5813a
TPCK 25 lmol/L ND 6912a 7314a ND Since previous papers described the activation of NF-B
PDTC 150 lmol/L ND 7515a ND 6813a during experimental glomerulonephritis [32, 38], in the
Genistein 150 lmol/L 4313a 419a 508a 466a
next set of experiments we studied the simultaneous lo-Parthenolide 10 lmol/L 5812a 5610a 6510a 6312a
PD98059 50 lmol/L 1710b 229b ND 2112b calization of the iNOS protein and the transcription fac-
SB203580 30 lmol/L 2010b 188b ND 1913b tor. Therefore, we subsequently performed Southwest-
Fc fragments 100 lg/mL 759a 7110a 7316a 684a
ern histochemistry with consensus oligonucleotide forF(ab
)2 fragments 100 lg/mL ND 135b ND 93b
NF-B and standard immunohistochemistry with anti-Abbreviations are in the Appendix. Growth-arrested cells were pretreated
during 90 minutes with the indicated inhibitors and then incubated for 60 minutes iNOS Ab. As shown in Figure 7D, colocalization of
with IC (100 g/mL). Cells were lysed and the NF-B binding activity in nuclear NF-B (nuclear staining in dark) and iNOS (cytoplasmicextracts was analyzed by gel shift assay as described. Data of densitometry are
expressed as percentage of inhibition vs. IC-treated cells and are mean  SD staining in brown) was observed in several glomerular
of 3 to 5 experiments.
and tubular cells, suggesting that in vivo activation ofa,b P  0.01 and not significant vs. IC alone, respectively
this factor may be involved in the transcriptional regula-
tion of iNOS.
MBP as the substrate. The kinetics of p38 and ERK Implication of FcR in renal cell activation by IC
activation in human MC induced by IgA-IC was consis- To analyze whether IC activate MC and monocytes
tent with the phosphorylation assay (Fig. 6). Incubation by a FcR-dependent mechanism, cells were incubated
of cells with the MEK inhibitor PD98059 avoided the with different fragments obtained by enzymatic digestion
phosphorylation of ERK, but had no effect on activation of Igs. In human MC, the presence of IgA or IgG Fc
of p38. Similarly, blocking p38 had no effect on either fragments in the incubation medium reduced NO pro-
phosphorylation levels or kinase activity of ERK (data duction induced by IgA-IC or IgG-IC (71  2 and 74 
not shown) 3% inhibition, N  4), whereas no inhibition was ob-
served in the presence of F(ab´)2 or Fab fragments. IniNOS expression and NF-B activation in
IC-stimulated monocytes, pretreatment with Fc frag-experimental glomerulonephritis
ments attenuated the luciferase activity of 0.7kb-piNOS-Our previous studies described the evolution of the
Luc plasmid (Fig. 8A) and the iNOS mRNA expressionIC proliferative glomerulonephritis, which is character-
(IgA Fc fragments, 66  6% inhibition, N  4). By gelized by marked glomerular immune deposits, cell prolif-
shift assay, a marked decrease in NF-B activity waseration, matrix accumulation, inflammatory cell infiltra-
detected in the presence of Fc, but not F(ab
)2 fragments,tion, and intense proteinuria [32, 33]. Then, we evaluated
in both cell types (Table 1). Additionally, the nuclearwhether overexpression of iNOS could be implicated
translocation of p65/p50 heterodimer induced by IC inin the pathogenesis of IC-mediated glomerulonephritis,
human MC (Fig. 8 B, C) was prevented by Fc fragmentsanalyzing iNOS expression levels in two different phases
(Fig. 8 D, E).of the experimental model. Moderate proteinuria and
To evaluate in vivo whether the interaction of IC withmesangial immune deposits appear in the mild phase,
FcR is responsible for the increased iNOS expression inwhile the severe phase is characterized by intense pro-
renal tissues, animals with ongoing nephritis were treatedteinuria, morphological lesions and immune deposits in
with IgG Fc fragments and followed for one and twothe mesangium and glomerular capillary wall [32, 33].
weeks. We have previously demonstrated that Fc frag-The renal mRNA expression of iNOS was measured
ment administration prevents the development of renalby RT-PCR on cortex samples, and the results were
injury in experimental immune glomerulonephritis [32].expressed as ratio of iNOS/GAPDH expression. Control
Consistent with these data, the renal iNOS expressionanimals presented very low expression levels of iNOS
(mRNA and protein) was decreased in animals injectedmRNA, which were increased after induction of the dis-
with Fc fragments as compared with untreated nephriticease, being markedly higher (5-fold vs. control) in the
animals, observing significant differences after one andsevere phase of nephritis (Fig. 7A). By immunohisto-
two weeks of study (Table 2). The decrease in iNOS ex-chemistry, few glomerular and tubular cells positive for
pression was temporally associated with a reduction iniNOS protein were observed in the kidney of healthy
proteinuria levels and glomerular lesions. No changes incontrol rats (not shown). In diseased kidney, iNOS pro-
tein was increased in glomeruli, with positivity found proteinuria, renal morphology and iNOS expression were
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Fig. 6. Activation of MAPK by IC in human MC. Cells were exposed to IgA-IC for different periods of time and the activation of p38 (A) and
ERK (B) in the cell lysates was analyzed. Phosphorylation of p38 and ERK () was detected by immunoblotting with phospho-specific Abs to
each of the MAPK. For MAPK activity ( ), proteins were immunoprecipitated with anti-p38 or anti-ERK Abs, and kinase assay was made using
MBP as substrate. As control, total cell lysates and immunoprecipitates were immunoblotted with anti-p38 or anti-ERK Abs. Densitometric relative
units are expressed as fold increase vs. control conditions. Results are representative of three independent experiments.
observed in healthy control rats receiving daily injection of acute immune glomerulonephritis and lupus nephritis
have described the protective effects of blocking NOof Fc fragments for two weeks (Table 2).
production in the development of proteinuria and renal
lesions [12, 13]. In contrast, NOS inhibition in other mod-
DISCUSSION
els of immune renal injury presented deleterious effects,
This study demonstrates that IC alone modulate NO such as increased proteinuria and intraglomerular coagu-
generation by inducing iNOS in infiltrating and renal lation [3, 14]. This controversy suggests that immune-
resident cells through a mechanism involving FcR activa- mediated renal disease probably will not be effectively
tion. Moreover, in these cells, activation of the MAPK treated in a very distal point to the IC deposition.
pathway and translocation of NF-B into the nucleus It has previously been described that the major source
are important steps in overexpression of iNOS upon IC for NO production in the nephritic glomerulus seems
activation. to be the monocytes/macrophages [9]. NO also can be
Exposure of cultured cells to IC was accompanied by produced by neutrophils in the acute phase of immune
a marked time-dependent increase in steady-state iNOS glomerulonephritis, although glomerular iNOS inhibi-
mRNA levels, which was initially detected after few hours tion does not affect the primary mechanism of injury
of incubation, peaked at 7 to 14 hours and decreased (leukocyte infiltration) [12]. However, the concomitant
after 48 hours. The kinetics of iNOS expression in mono- participation of intrinsic glomerular cells in the synthesis/
cytes was different, and had a linear pattern. The iNOS release of NO during glomerular inflammation cannot
is a ubiquitous enzyme, but the degree of NO production be excluded, since iNOS induction in different cells may
in response to the same stimuli is closely associated with peak at different time points. In our experimental model
the cell type-specific function [1, 3]. This regulatory com- of immune glomerulonephritis in rats (mild and severe
plexity reflects the inducibility of the iNOS gene, and phase) there was an up-regulation of the renal iNOS
may explain why monocytes produce larger amounts of expression in temporal association with the appearance
nitrites than MC in response to the same concentration of proteinuria and glomerular lesions (proliferation and
of IC. inflammatory infiltration). Moreover, increased iNOS
Renal iNOS activity is significantly increased in vari- expression was detected even in the mild phase of the
ous pathophysiological conditions, including glomerulo- disease, which is characterized by moderate proteinuria
nephritis, tubulointerstitial nephritis and sepsis [2, 3, 8–11], and renal lesions, and mesangial IC deposits [32, 33].
suggesting a role for NO in the pathogenesis of immune- This is consistent with previous data showing increased
mediated inflammation. Recent reports using non-selec- glomerular iNOS expression in renal biopsies from pa-
tients with proliferative forms of lupus nephritis and IgAtive or iNOS-specific inhibitors in experimental models
Go´mez-Guerrero et al: NO induction by immune complexes 2031
Fig. 7. Expression of iNOS in experimental
immune complex glomerulonephritis. (A) The
RNA from renal cortex of healthy control ani-
mals and rats with nephritis (mild and severe
phases) was reverse transcribed and a PCR re-
action (33 cycles) was performed with specific
primers for rat iNOS, and GAPDH as control.
Blot is representative of 4 different experiments.
(B, C) Immunohistochemical detection of iNOS
protein in renal tissues was analyzed by immu-
noperoxidase and semiquantitatively graded
in a scale 0 to 3. (B) In animals with severe
nephritis the strong iNOS staining was local-
ized in the cytoplasm of resident and infiltrat-
ing cells. (C) The iNOS score was represented
against the proteinuria levels of each individ-
ual (correlation coefficient r  0.973). (D)
Colocalization of activated NF-B and iNOS
in nephritic rats was analyzed by Southwest-
ern histochemistry with digoxigenin-labeled
NF-B oligonucleotides followed by immu-
noperoxidase with anti-iNOS. The arrows in-
dicate the double staining, positive nucleus
(NF-B) surrounded by a brown cytoplasm
(iNOS) in glomerulus and tubule. Magnifica-
tion 200.
Fig. 8. FcR are involved in the iNOS expres-
sion and NF-B activation induced by IC. (A)
Monocytic cells THP-1 cotransfected with 0.7
kb piNOS-Luc and pRL-TK were stimulated
for 24 hours with 200 g/mL of monomeric Igs
or IC (in the presence or absence of Fc frag-
ments). Data are the mean  SD of 4 experi-
ments in duplicate (*P  0.05 vs. control un-
stimulated cells). Symbols are: ( ), IC; ( ),
IC  Fc fragments; (), monomeric. (B–E )
Human MC were stimulated with IgA-IC (100
g/mL, 60 min) in the absence (B, C) or pres-
ence (D, E) of 100 g/mL IgA Fc fragments.
Nuclear translocation of p65 (B, D) and p50
(C, E) subunits of activated NF-B complex
was detected by immunofluorescence analysis.
Micrographs are representative of three inde-
pendent experiments.
Table 2. In vivo blockade of FcR in rats with immune glomerulonephritis reduces iNOS renal expression
Nephritis Control
1 week 2 weeks 2 weeks
UN (N  3) Fc (N  4) UN (N  4) Fc (N  4) UN (N  4) Fc (N  4)
iNOS mRNA 2.40.3a 1.30.2b 5.20.9a 1.50.4c 1.00.1 1.10.1
iNOS protein 1.90.2a 1.00.1a,b 2.70.2a 1.10.2a,c 0.20.1 0.20
Glomerular lesions 2.10.1a 0.90.1a,b 2.80.2a 1.30.2a,c 00 00
Proteinuria 22960a 7712a,b 38631a 8516a,c 81 71
The RNA from renal cortex of control animals, rats with untreated (UN) nephritis or treated with 5 mg/kg of Fc fragments (Fc) was isolated and analyzed in
triplicate by RT-PCR for rat iNOS. After densitometry of the iNOS band and correction by GAPDH, data were expressed as fold increases with respect to untreated
control. Immunohistochemical detection of iNOS protein and glomerular lesions in renal tissues were analyzed by immunoperoxidase and Masson’s staining,
respectively, and semiquantitatively graded in a scale of 0 to 3. Urinary protein excretion was expressed as mg/24 h. Results are mean  SD of the total number of
animals from each group analyzed in duplicate.
a P  0.01 vs. untreated control rats
P  0.01 vs. untreated nephritic rats after b one or c two weeks of study
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nephropathy, but not in non-proliferative diseases [3, 10]. expression, and they may be classified into antioxidants,
protease inhibitors, and IB phosphorylation blockersWe showed that iNOS protein could be synthesized not
only by infiltrating cells but also by resident glomerular [35–37]. In our work, pharmacological modulation of
NF-B activation with agents inhibiting NF-B pathwaycells (principally MC) and tubular cells. Similarly, in
human glomerulonephritis, double immunohistochemi- at different stages produced parallel effects on iNOS
expression and nitrite production, suggesting that NF-Bcal labeling for iNOS and macrophages (anti-CD 68)
showed that most of the iNOS staining was present in sites may be essential for iNOS induction by IC in cul-
tured MC and monocytes. Moreover, NF-B activationCD68 negative cells, which morphologically could have
been mesangial or visceral epithelial cells [10]. and iNOS expression were simultaneously detected in
glomerular and tubular cells of nephritic rats, since bothIn cultured MC and monocytes, whereas IC induced
high levels of iNOS and NO, monomeric Igs caused only mediators appeared colocalized in the same cells (nu-
clear staining for NF-B and cytoplasmic staining fora small increase, and none was detected when the cells
were treated with F(ab
)2 fragments. Additionally, incu- iNOS). These data indicate that NF-B has an important
role in iNOS expression, although we do not discard thebation with Fc fragments prior to IC stimulation pre-
vented iNOS induction and NO release. These data con- contribution of other signaling cascades in concert with
NF-B as crucial for iNOS induction by IC in renal cells.firm that specific FcR for IgA or IgG are involved in
IgA-IC or IgG-IC cell activation, as previously reported The intracellular mechanisms controlling NO synthe-
sis by different cell types are the subject of current inter-[18, 24–28]. To confirm these data in vivo, we evaluated
the effects of FcR blockade on the protection from high est. Thus, the expression of iNOS appears to be regulated
in a cell-specific manner by several protein kinases [42].output NO release and glomerulonephritis. Treatment
with Fc fragments (inhibitors of IC binding to FcR in Interestingly, the involvement of MAPK in iNOS induc-
tion is diverse, since the principal family members (ERK,cultured cells) largely prevented iNOS mRNA and pro-
tein expression in infiltrating and resident cells, together p38, JNK) may play a positive, negative or neutral regu-
latory role—depending on the stimulus and cell type—inwith an improvement in the renal lesions. These data
are consistent with our previous article showing the pre- iNOS expression [43, 44]. We observed that NO genera-
tion and iNOS expression in MC and monocytes werevention of proteinuria, cytokine production and matrix
accumulation in the immune nephritis by Fc fragment attenuated by a general tyrosine kinase inhibitor (gen-
istein) and specific inhibitors of MEK (PD98059) andadministration [32], and expands the concept that FcR
may have a key role in the initiation/progression of in- p38 MAPK (SB203580) (a pharmacological inhibitor of
JNK is not commercially available). This indicates thatflammatory responses during immune glomerular injury.
The iNOS gene has multiple transcription factor bind- tyrosine kinases and MAPK play a positive regulatory
role in the induction of iNOS by IC. Other authors de-ing sequences, including NF-B sites [4, 15]. The tran-
scriptional regulation of iNOS gene was studied using scribed that tyrosine phosphorylation mediates iNOS
up-regulation by insoluble IgG-IC in rat peritoneal mac-two fragments from the 5
 regulatory region of the iNOS.
The 0.7 kb fragment contains consensus sequences of rophages [20]. The activation of tyrosine kinases by IC
also was reported previously in MC [28, 31], but this isthe TATA box, Oct-1, NF-IL-6, NF-B and TNF-RE,
all included in the 0.3 kb fragment, and also contains the first study describing the involvement of the MAPK
family in the signaling pathways activated by FcR inadditional -IRE and AP-1 sites [4, 7]. The data obtained
with MC and monocytes transfected with these two plas- these cells.
The involvement of MAPK in the activation of NF-Bmids indicate that, although NF-B activation represents
a crucial step in the transcription of iNOS, it is possible in different systems has been illustrated by numerous
reports. Thus, p38/ERK and ERK/JNK cascades are re-that other promoter elements, such as AP-1, may be
necessary for maximal iNOS gene induction. This is com- quired for activation of NF-B regulated genes by cyto-
kines and antioxidants [45, 46]. Our data demonstratepatible with previous studies suggesting that other tran-
scription factors can physically associate with and/or syn- activation of p38 and ERK by IC, temporally consistent
with the kinetics of NF-B activation and iNOS expres-ergize with NF-B for full induction of the iNOS gene
in other systems [39, 40]. sion. However, studies employing specific inhibitors of
MAPK members revealed that either IB phosphoryla-Studies in experimental and human glomerulonephri-
tis have provided some evidence to support the involve- tion, composition of the activated NF-B complex or
DNA-binding ability were independent of the activationment of the transcription factor NF-B in the pathogene-
sis of glomerulonephritis [32, 38]. Additionally, increased of MEK and p38 cascades. Indeed, although NF-B and
MAPK activation is mediated by different pathways,expression of NF-B–dependent genes, such as chemo-
kines and adhesion molecules has been demonstrated in both may converge downstream, as previously reported
in other systems [47]. Therefore, we hypothesize thatglomerular cells [19, 28, 41]. Various reagents have al-
ready proven effective in inhibiting NF-B-inducible gene activation of downstream members in the MAPK path-
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Fig. 9. Schematic summary of IC-activated
signaling pathways controlling iNOS expres-
sion in MC and monocytes. Multiple cascades
are activated by FcR that culminate in activa-
tion of NF-B pathway, in which MAPK mem-
bers appear necessary for inducing full expres-
sion of iNOS. Dotted lines show the paths
of action of the different MAPK and NF-B
inhibitors used in this study.
Reprint requests to Carmen Go´mez-Guerrero, Ph.D., Renal and Vas-way may function as transactivation factors of NF-B at
cular Research Lab, Fundacio´n Jime´nez Dı´az, Avda. Reyes Cato´licos,
the nuclear level, or that MAPK may activate other un- 2, 28040 Madrid, Spain.
E-mail: cgomez@fjd.escharacterized transcription factors that can directly or
indirectly be involved in transcriptional control of IC-
induced iNOS. APPENDIX
Taken together, our results indicate that FcR stimula-
Abbreviations used in this article are: AP-1, activator protein-1;tion induces iNOS expression in renal resident and infil-
FcR, Fc receptors; GAPDH, glyceraldehyde-3-phosphate dehydroge-
trating cells by a mechanism involving activation of tyro- nase; IC, immune complexes; IFN-, interferon-; Ig, immunoglobulin;
IL-1, interleukin-1; iNOS, inducible nitric oxide synthase; L-NAME,sine kinases, MAPK and NF-B pathways (Fig. 9), and
N-nitro-l-arginine methyl ester; LPS, lipopolysaccharide; MC, mesan-suggest that NO may play an important role in IC-medi- gial cells; mAb, monoclonal antibody; MEK, ERK kinase; MAPK,
ated glomerular injury. The present data support the idea mitogen-activated protein kinase; MBP, myelo basic protein; NF-B,
nuclear factor-B; NO, nitric oxide; PDTC, pyrrolidine dithiocarba-that development of NOS inhibitors, including poten-
mate; rh, recombinant human; TNF-, tumor necrosis factor-.tial NF-B and MAPK regulating drugs, may represent
a novel therapeutic approach for immune glomerulo-
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